Globular adiponectin increases cGMP formation in blood platelets independently of nitric oxide

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 12, 2008, Pages 2121-2131

  Riba, R ^a   Patel, B ^a   Aburima, A ^a   Naseem, Khalid M ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Adiponectin; Heat shock protein 90; Nitric oxide; Phosphorylation; Platelets; Soluble guanylyl cyclase

Indexed keywords

ADIPONECTIN; CALCIUM ION; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; GUANYLATE CYCLASE; HEAT SHOCK PROTEIN 90; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ADIPONECTIN; ANIMALS; BLOOD PLATELETS; CATTLE; CELL ADHESION MOLECULES; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; HUMANS; MICROFILAMENT PROTEINS; NITRIC OXIDE; PHOSPHOPROTEINS; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 56749096780     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.03179.x     Document Type: Article

References (37)

1. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, Waldman SA. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 2000; 52: 375-414.
2. de Graaf JC, Banga JD, Moncada S, Palmer RM, de Groot PG, Sixma JJ. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 1992; 85: 2284-90.
3. Schwarz UR, Walter U, Eigenthaler M. Taming platelets with cyclic nucleotides. Biochem Pharmacol 2001; 62: 1153-61.
4. Naseem KM, Riba R. Unresolved roles of platelet nitric oxide synthase. J Thromb Haemost 2008; 6: 10-19.
5. Freedman JE, Loscalzo J, Barnard MR, Alpert C, Keaney JF, Michelson AD. Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest 1997; 100: 350-6.
6. Freedman JE, Sauter R, Battinelli EM, Ault K, Knowles C, Huang PL, Loscalzo J. Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene. Circ Res 1999; 84: 1416-21.
7. Iafrati MD, Vitseva O, Tanriverdi K, Blair P, Rex S, Chakrabarti S, Varghese S, Freedman JE. Compensatory mechanisms influence hemostasis in setting of eNOS deficiency. Am J Physiol Heart Circ Physiol 2005; 288: H1627-32.
8. Li Z, Xi X, Gu M, Feil R, Ye RD, Eigenthaler M, Hofmann F, Du X. A stimulatory role for cGMP-dependent protein kinase in platelet activation. Cell 2003; 112: 77-86.
9. Li Z, Zhang G, Feil R, Han J, Du X. Sequential activation of p38 and ERK pathways by cGMP-dependent protein kinase leading to activation of the platelet integrin alphaIIb beta3. Blood 2006; 107: 965-72.
10. Riba R, Hughes CE, Graham A, Watson SP, Naseem KM. Globular adiponectin induces platelet activation through the collagen receptor GPVI-Fc receptor gamma chain complex. J Thromb Haemost 2008; 6: 1012-20.
11. Cheng KK, Lam KS, Wang Y, Yu H, Carling D, Wu D, et al. Adiponectin-induced eNOS activation and nitric oxide production are mediated by APPL1 in endothelial cells. Diabetes 2007; 56: 1387-94.
12. Morton LF, Hargreaves PG, Farndale RW, Young RD, Barnes MJ. Integrin alpha 2 beta 1-independent activation of platelets by simple collagen-like peptides: Collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for alpha 2 beta 1-independent platelet reactivity. Biochem J 1995; 306 (Pt 2): 337-44.
13. Patel B, Sharifi M, Milward AD, Oberprieler NG, Gibbins JM, Parkin S, Naseem KM. Platelet nitric oxide synthase is activated by tyrosine dephosphorylation: Possible role for SHP-1 phosphatase. J Thromb Haemost 2006; 4: 2423-32.
14. Riba R, Sharifi M, Farndale RW, Naseem KM. Regulation of platelet guanylyl cyclase by collagen: Evidence that glycoprotein-VI mediates platelet nitric oxide synthesis in response to collagen. Thromb Haemost 2005; 94: 395-403.
15. Butt E, Abel K, Krieger M, Palm D, Hoppe V, Hoppe J, Walter U. cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets. J Biol Chem 1994; 269: 14509-17.
16. Milward AD, Riba R, Patel B, Oberprieler NG, Naseem KM. Sodium orthovanadate induced tyrosine phosphorylation of platelet nitric oxide synthase negatively regulates enzyme activity. Biochim Biophys Acta 2006; 1760: 1411-17.
17. Chen ZJ, Che D, Vetter M, Liu S, Chang CH. 17beta-Estradiol inhibits soluble guanylate cyclase activity through a protein tyrosine phosphatase in PC12 cells. J Steroid Biochem Mol Biol 2001; 78: 451-8.
18. Ferrero R, Rodriguez-Pascual F, Miras-Portugal MT, Torres M. Nitric oxide-sensitive guanylyl cyclase activity inhibition through cyclic GMP-dependent dephosphorylation. J Neurochem 2000; 75: 2029-39.
19. Murthy KS. Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle. Biochem J 2001; 360: 199-208.
20. Zwiller J, Revel MO, Basset P. Evidence for phosphorylation of rat brain guanylate cyclase by cyclic AMP-dependent protein kinase. Biochem Biophys Res Commun 1981; 101: 1381-7.
21. Kostic TS, Andric SA, Stojilkovic SS. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5′-monophosphate production in pituitary cells. Mol Endocrinol 2004; 18: 458-70.
22. Papapetropoulos A, Zhou Z, Gerassimou C, Yetik G, Venema RC, Roussos C, Sessa WC, Catravas JD. Interaction between the 90-kDa heat shock protein and soluble guanylyl cyclase: Physiological significance and mapping of the domains mediating binding. Mol Pharmacol 2005; 68: 1133-41.
23. Schmidt HH, Lohmann SM, Walter U. The nitric oxide and cGMP signal transduction system: Regulation and mechanism of action. Biochim Biophys Acta 1993; 1178: 153-75.
24. Jensen BO, Selheim F, Doskeland SO, Gear AR, Holmsen H. Protein kinase A mediates inhibition of the thrombin-induced platelet shape change by nitric oxide. Blood 2004; 104: 2775-82.
25. Marshall SJ, Senis YA, Auger JM, Feil R, Hofmann F, Salmon G, Peterson JT, Burslem F, Watson SP. GPIb-dependent platelet activation is dependent on Src kinases but not MAP kinase or cGMP-dependent kinase. Blood 2004; 103: 2601-9.
26. Gambaryan S, Geiger J, Schwarz UR, Butt E, Begonja A, Obergfell A, Walter U. Potent inhibition of human platelets by cGMP analogs independent of cGMP-dependent protein kinase. Blood 2004; 103: 2593-600.
27. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000; 102: 1296-301.
28. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, Funahashi T, Walsh K. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 2004; 279: 1304-9.
29. Stasch JP, Schmidt P, Alonso-Alija C, Apeler H, Dembowsky K, Haerter M, Heil M, Minuth T, Perzborn E, Pleiss U, Schramm M, Schroeder W, Schroder H, Stahl E, Steinke W, Wunder F. NO- and haem-independent activation of soluble guanylyl cyclase: Molecular basis and cardiovascular implications of a new pharmacological principle. Br J Pharmacol 2002; 136: 773-83.
30. Riba R, Oberprieler NG, Roberts W, Naseem KM. Von Willebrand factor activates endothelial nitric oxide synthase in blood platelets by a GPIb-dependent mechanism. J Thromb Haemost 2006; 12: 2638-44.
31. Meurer S, Pioch S, Gross S, Muller-Esterl W. Reactive oxygen species induce tyrosine phosphorylation of and Src kinase recruitment to NO-sensitive guanylyl cyclase. J Biol Chem 2005; 280: 33149-56.
32. Gambaryan S, Kobsar AL, Hartmann S, Kuhlencordt PJ, Lohmann SM, Walter UB. No-synthase/NO independent regulation of human and murine platelet soluble guanylyl cyclase. J Thromb Haemost 2008; 6: 1376-84.
33. Agullo L, Garcia-Dorado D, Escalona N, Ruiz-Meana M, Mirabet M, Inserte J, Soler-Soler J. Membrane association of nitric oxide-sensitive guanylyl cyclase in cardiomyocytes. Cardiovasc Res 2005; 68: 65-74.
34. Saklatvala J, Rawlinson L, Waller RJ, Sarsfield S, Lee JC, Morton LF, Barnes MJ, Farndale RW. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue. J Biol Chem 1996; 271: 6586-9.
35. Takahashi S, Mendelsohn ME. Calmodulin-dependent and -independent activation of endothelial nitric-oxide synthase by heat shock protein 90. J Biol Chem 2003; 278: 9339-44.
36. Moraes LA, Paul-Clark MJ, Rickman A, Flower RJ, Goulding NJ, Perretti M. Ligand-specific glucocorticoid receptor activation in human platelets. Blood 2005; 106: 4167-75.
37. Nedvetsky PI, Meurer S, Opitz N, Nedvetskaya TY, Muller H, Schmidt HH. Heat shock protein 90 regulates stabilization rather than activation of soluble guanylate cyclase. FEBS Lett 2008; 582: 327-31.